Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome. Graeme L Fraser et al

prediction models for primary ovarian insufficiency (POI) in long-term survivors of childhood cancer by Cindy Im et al Lancet Oncol 2023 Nov 13